Our take on the latest news and views on data.

Relevant company news, articles, podcasts, and blog posts.

Recent Posts

Industry Trends

Clinical Trial Trends

Disease Area Trends

Recent Tweets

💊 SPDR Pharma $XPH Movers Today 💉

Top 3 XPH Gainers:
$AMRX (Amneal Pharma) 3.55% 📈
$RLMD (Relmada Ther.) 3.87% 📈
$CORT (Corcept Ther.) 4.43% 📈

Top 3 XPH Laggards:
$FULC (Fulcrum Ther.) -8.8% 🔻
$RVNC (Revance Ther.) -6.0% 🔻
$OMER (Omeros) -5.5% 🔻

🧬 SPDR Biotech $XBI Movers Today 🩸

Top 3 XBI Gainers:
$RXRX (Recursion) 5.57% 📈
$TSVT (2seventy) 21.55% 📈
$KRTX (Karuna) nan% 📈

Top 3 XBI Laggards:
$ARQT (Arcutis Bio) -9.9% 🔻
$MRSN (Mersana) -8.9% 🔻
$BMEA (Biomea Fusion) -8.5% 🔻

FDA approves first MASH drug for fatty liver disease: Madrigal's Rezdiffra https://buff.ly/3viaSCc $MDGL #FDA #fattyliver #innovation #pharma

OBI Pharma to present posters on OBI-992 and GlycOBI ADC platform at AACR 2024 Annual Meeting.

More Info: https://pryzm.ozmosi.com/product/32268 $XBI $IBB $XPH $PPH

Load More

Get Started with OZMOSI

We synthesize and process insights, delivering what you need quickly, effectively, and efficiently.

600 Warren Ave,
Spring Lake, NJ 07762